As the global demand for obesity treatments skyrockets, Vikrant Shrotriya discusses the complex nature of obesity, the science behind weight management, and the role of medications like Ozempic in ...

Vikrant Shrotriya, Novo Nordisk India's Managing Director, addressed concerns over the side effects of Ozempic during a session at India Today Conclave 2025. He said that the weight-loss drug has been ...

Exclusive: Vikrant Shrotriya, Corporate Vice President & Managing Director, Novo Nordisk India, has warned that the ‘wonder drug’ Ozemic is not a ‘party drug’. In a special conversation ...

Conclave explores obesity as a metabolic disease, the role of medication like Ozempic, and holistic weight loss strategies, ...

Obesity is not just a lifestyle issue but a chronic disease that requires sustained medical intervention, said Vikrant Shrotriya, Managing Director of Novo Nordisk India, at the India Today ...